American Association for Cancer Research

sorry, we can't preview this file

crc-22-0023-s03.docx (12.84 kB)

Supplementary Figure Legends from Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast Cancer

Download (12.84 kB)
journal contribution
posted on 2023-04-04, 01:22 authored by Margaret L. Axelrod, Yu Wang, Yaomin Xu, Xiaopeng Sun, Cosmin A. Bejan, Paula I. Gonzalez-Ericsson, Sara Nunnery, Riley E. Bergman, Joshua Donaldson, Angel L. Guerrero-Zotano, Chiara Massa, Barbara Seliger, Melinda Sanders, Ingrid A. Mayer, Justin M. Balko

Legends for Supplementary Figures 1-3


Susan G. Komen (SGK)

HHS | NIH | National Cancer Institute (NCI)

U.S. Department of Defense (DOD)

Vanderbilt-Ingram Cancer Center (VICC)

HHS | National Institutes of Health (NIH)

Dr. Mildred Scheel Stiftung für Krebsforschung

Deutsche Krebshilfe (German Cancer Aid)



Biomarkers are needed in breast cancer to identify patients at risk for recurrence. Blood is an attractive site for biomarker identification due to the relative ease of longitudinal sampling. Our study suggests that blood-based gene expression and cell-type abundance biomarkers may have clinical utility in breast cancer.